Lo Loestrin Fe is widely covered and available at $0 out-of-pocket cost for many patients5,6
● ~80% of commercially insured patients can access Lo Loestrin Fe6
● ~58% of Lo Loestrin Fe prescriptions were filled at $0 out-of-pocket cost5
● ~80% of commercially insured patients can access Lo Loestrin Fe6
● ~58% of Lo Loestrin Fe prescriptions were filled at $0 out-of-pocket cost5
Source: Managed Markets Insight and Technology, LLC™, a trademark of MMIT, as of 7/15/2022.
Data are subject to change. Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits are determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient's coverage with applicable insurer. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.
REFERENCES
1. IQVIA® National Prescription Audit® - TRx/EUTRx Data: November 2022 – February 2023 (claim derived from the use of information under license from IQVIA, which expressly reserves all
rights, including rights of copying, distribution, and republication). 2. IQVIA® Patients Insights New To Brand (NBRx) Data: since launch – January 2023 (claim derived from the use of
information under license from IQVIA, which expressly reserves all rights, including rights of copying, distribution, and republication). 3. Lo Loestrin® Fe prescribing information. Madison, NJ:
Allergan USA, Inc. 4. U.S. Food and Drug Administration. The Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Available from: https://
www.accessdata.fda.gov/scripts/cder/ob/. Accessed July 2022. 5. Data on file. Allergan USA, Inc.: Madison, NJ. 6. Managed Markets Insight and Technology, LLC™, a trademark of MMIT.
Database as of March 2022. Data are subject to change. 7. Junel® Fe 1/20 prescribing information. North Wales, PA: Teva Pharmaceuticals USA; 2017. 8. The Alan Guttmacher Institute.
Next Steps for America’s Family Planning Program: Leveraging the Potential of Medicaid and Title X in an Evolving Health Care System. https://www.guttmacher.org/sites/default/files/
report_pdf/nextsteps.pdf. Accessed July 2022. 9. Previfem® prescribing information. Huntsville, AL: Qualitest Pharmaceuticals; 2015. 10. Microgestin® Fe 1.5/30 prescribing information.
Greenville, NC: Mayne Pharma; 2020. 11. Ortho Tri-Cyclen® Lo prescribing information. Titusville, NJ: Janssen Pharmaceuticals, Inc; 2019. 12. Nakajima ST, Archer DF, Ellman H.
Contraception. 2007;75(1):16-22. 13. Willis SA, Kuehl TJ, Spiekerman AM, Sulak PJ. Contraception. 2006;74(2):100-103. 14. Spona J, Elstein M, Feichtinger W, et al. Contraception.
1996;54(2):71-77. 15. Archer OF, Nakajima ST, Sawyer AT, et al. Obstet Gynecol. 2013;122(3):601-607.